Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment
Gingival Crevicular Fluid (GCF) Bactericidal/Permeability-increasing Protein (BPI) and Interleukin (IL)-1beta in Periodontitis Patients: Non-surgical Periodontal Treatment Effects
1 other identifier
interventional
30
1 country
2
Brief Summary
The aim of this study was to examine the relationship between healing response after non-surgical periodontal treatment and baseline gingival crevicular fluid (GCF) levels of bactericidal/permeability-increasing protein (BPI) and interleukin-1beta (IL-1ß).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2020
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedApril 9, 2024
April 1, 2024
10 months
March 7, 2024
April 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Gingival crevicular fluid Bactericidal/permeability-increasing proteins levels
Gingival Crevicular Fluid Bactericidal Permeability Increasing Protein levels in periodonitis patients after Non-surgical periodontal treatment
through study completion, an average of 1 year
Secondary Outcomes (1)
Gingival crevicular fluid interleukin-1Beta levels
through study completion, an average of 1 year
Study Arms (1)
Healty
EXPERIMENTALNon-surgical periodontal treatment
Interventions
Scaling and root planing in two sessions over the course of a 48-hour period comprised the standard treatment procedure
Eligibility Criteria
You may qualify if:
- Systemically healthy,
- Stage II or III, Grade A periodontitis
- Having at least 20 permanent teeth (excluding third molars and any tooth loss induced by -non-periodontal causes).
You may not qualify if:
- Smoking,
- use of alcohol; pregnancy or lactation; intake ofantibiotics, steroidal or non-steroidal anti-inflammatory drugs within the last 6 months
- having received periodontal treatment within the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Akdeniz Üniversity
Antalya, 07070, Turkey (Türkiye)
Akdeniz Üniversitesi Diş Hekimliği Fakültesi
Antalya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 7, 2024
First Posted
April 9, 2024
Study Start
November 19, 2019
Primary Completion
September 20, 2020
Study Completion
September 20, 2020
Last Updated
April 9, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share